CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $168,206 | -22.3% | 193,363 | 0.0% | 0.00% | – |
| Q2 2023 | $216,567 | +7.7% | 193,363 | 0.0% | 0.00% | – |
| Q1 2023 | $201,098 | -53.6% | 193,363 | -50.0% | 0.00% | – |
| Q4 2022 | $433,134 | +97.8% | 386,726 | +100.0% | 0.00% | – |
| Q3 2022 | $219,000 | -22.9% | 193,363 | 0.0% | 0.00% | – |
| Q2 2022 | $284,000 | -35.9% | 193,363 | 0.0% | 0.00% | – |
| Q1 2022 | $443,000 | -12.5% | 193,363 | +5.2% | 0.00% | – |
| Q4 2021 | $506,000 | -54.1% | 183,888 | 0.0% | 0.00% | – |
| Q3 2021 | $1,103,000 | +36.8% | 183,888 | +11.1% | 0.00% | – |
| Q2 2021 | $806,000 | +722.4% | 165,588 | +316.7% | 0.00% | – |
| Q1 2021 | $98,000 | -33.3% | 39,740 | -26.0% | 0.00% | – |
| Q4 2020 | $147,000 | +77.1% | 53,700 | 0.0% | 0.00% | – |
| Q3 2020 | $83,000 | -17.8% | 53,700 | 0.0% | 0.00% | – |
| Q2 2020 | $101,000 | +11.0% | 53,700 | 0.0% | 0.00% | – |
| Q1 2020 | $91,000 | -41.7% | 53,700 | 0.0% | 0.00% | – |
| Q4 2019 | $156,000 | +358.8% | 53,700 | 0.0% | 0.00% | – |
| Q3 2019 | $34,000 | -34.6% | 53,700 | 0.0% | 0.00% | – |
| Q2 2019 | $52,000 | -92.7% | 53,700 | -89.7% | 0.00% | – |
| Q1 2019 | $717,000 | +50.3% | 519,621 | +16.5% | 0.00% | – |
| Q4 2018 | $477,000 | -83.3% | 446,063 | -3.7% | 0.00% | – |
| Q3 2018 | $2,848,000 | -32.3% | 463,193 | +17.7% | 0.00% | – |
| Q2 2018 | $4,208,000 | +22.2% | 393,564 | +22.6% | 0.00% | – |
| Q1 2018 | $3,444,000 | +70.4% | 321,025 | +11.3% | 0.00% | – |
| Q4 2017 | $2,021,000 | -13.9% | 288,410 | +7.3% | 0.00% | – |
| Q3 2017 | $2,346,000 | -0.9% | 268,726 | +3.5% | 0.00% | – |
| Q2 2017 | $2,367,000 | +129.8% | 259,599 | +99.7% | 0.00% | – |
| Q1 2017 | $1,030,000 | +13.1% | 129,978 | +27.1% | 0.00% | – |
| Q4 2016 | $911,000 | -7.0% | 102,278 | +80.7% | 0.00% | – |
| Q3 2016 | $980,000 | – | 56,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |